1996
Striatal dopamine D2 receptor quantification and superior temporal gyrus: Volume determination in 14 chronic schizophrenic subjects
Tune L, Barta P, Wong D, Powers R, Pearlson G, Tien A, Wagner H. Striatal dopamine D2 receptor quantification and superior temporal gyrus: Volume determination in 14 chronic schizophrenic subjects. Psychiatry Research 1996, 67: 155-158. PMID: 8876015, DOI: 10.1016/0925-4927(96)02728-x.Peer-Reviewed Original ResearchConceptsSuperior temporal gyral volumeSuperior temporal gyrusPositron emission tomographyGyral volumeTemporal gyrusNormal groupSchizophrenic groupStriatal D2 receptor densityChronic schizophrenic subjectsRight superior temporal gyrusD2 receptor densityDopamine D2 receptorsStructural neuroimaging techniquesControl subjectsD2 receptorsReceptor densityNormal subjectsPET scansResonance imagingEmission tomographySchizophrenic subjectsBmax valuesNeuroimaging techniquesGyrusReceptor quantification
1995
In Vivo D2 Dopamine Receptor Density in Psychotic and Nonpsychotic Patients With Bipolar Disorder
Pearlson G, Wong D, Tune L, Ross C, Chase G, Links J, Dannals R, Wilson A, Ravert H, Wagner H, DePaulo J. In Vivo D2 Dopamine Receptor Density in Psychotic and Nonpsychotic Patients With Bipolar Disorder. JAMA Psychiatry 1995, 52: 471-477. PMID: 7771917, DOI: 10.1001/archpsyc.1995.03950180057008.Peer-Reviewed Original ResearchConceptsSchizophrenic patientsBipolar disorderBmax valuesNonpsychotic patientsNormal controlsPsychotic symptomsPsychotic patientsAffective disordersPositron emission tomographic scansD2 dopamine receptor densityNeuroleptic-naive schizophrenic patientsPositron emission tomographic studiesDopamine receptor densityReceptor density valuesDSM-III criteriaPresent State ExaminationPresence of psychosisEmission tomographic studiesHigher Bmax valuesPsychotic bipolar disorderNeuroleptic medicationReceptor BmaxMood abnormalitiesReceptor valuesTomographic scan
1993
Dopamine D2 receptor density estimates in schizophrenia: A positron emission tomography study with11C-N-methylspiperone
Tune L, Wong D, Pearlson G, Strauss M, Young T, Shaya E, Dannals R, Wilson A, Ravert H, Sapp J, Cooper T, Chase G, Wagner H. Dopamine D2 receptor density estimates in schizophrenia: A positron emission tomography study with11C-N-methylspiperone. Psychiatry Research 1993, 49: 219-237. PMID: 7909948, DOI: 10.1016/0165-1781(93)90063-m.Peer-Reviewed Original ResearchConceptsPositron emission tomographySchizophrenic patientsBmax valuesEntire groupControl subjectsEmission tomographyDopamine D2 receptor densityNeuroleptic-free patientsDuration of illnessChronic schizophrenic patientsD2 receptor densityClinical characteristicsPatient populationReceptor abnormalitiesCorpus striatumClinical dataReceptor densityPatientsControl groupFunction of ageLate manifestationDifferent radioligandsFour-compartment modelSignificant differencesRadioligand
1988
D2 DOPAMINE RECEPTORS IN TOURETTE'S SYNDROME AND MANIC DEPRESSIVE ILLNESS
Wong D, Singer H, Pearlson G, Tune L, Ross C, Villemagne V, Dannals R, Links J, Wilson A, Ravert H, Wagner H, Gjedde A. D2 DOPAMINE RECEPTORS IN TOURETTE'S SYNDROME AND MANIC DEPRESSIVE ILLNESS. Clinical Nuclear Medicine 1988, 13: 392. DOI: 10.1097/00003072-198805000-00040.Peer-Reviewed Original ResearchManic-depressive illnessTourette syndromeDepressive illnessPsychotic symptomsD2 dopamine receptor densityDrug-free patientsDopamine receptor densityGreater clinical severityD2 dopamine receptorsOral haloperidolFree patientsMotor abnormalitiesAntagonist haloperidolClinical severityTourette patientsDopamine receptorsReceptor densityParkinson's diseaseCommon treatmentPsychiatric disordersActive psychosisSyndromePatientsAdult subjectsBmax values